The neurobiology of irritable bowel syndrome

EA Mayer, HJ Ryu, RR Bhatt - Molecular psychiatry, 2023 - nature.com
Irritable bowel syndrome (IBS) is the most prevalent disorder of brain-gut interactions that
affects between 5 and 10% of the general population worldwide. The current symptom …

Management of functional somatic syndromes and bodily distress

P Henningsen, S Zipfel, H Sattel, F Creed - Psychotherapy and …, 2018 - karger.com
Functional somatic syndromes (FSS), like irritable bowel syndrome or fibromyalgia and other
symptoms reflecting bodily distress, are common in practically all areas of medicine …

[PDF][PDF] Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options

PC Konturek, T Brzozowski, SJ Konturek - J Physiol Pharmacol, 2011 - jpp.krakow.pl
Stress, which is defined as an acute threat to homeostasis, shows both short-and long-term
effects on the functions of the gastrointestinal tract. Exposure to stress results in alterations of …

[HTML][HTML] Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

T Didari, S Mozaffari, S Nikfar… - World journal of …, 2015 - ncbi.nlm.nih.gov
METHODS: PubMed, Cochrane library, Scopus, Google Scholar, and Clinicaltrial. gov
databases were searched for literature published between September 2007 and December …

Current treatment options and therapeutic insights for gastrointestinal dysmotility and functional gastrointestinal disorders

R Singh, H Zogg, UC Ghoshal, S Ro - Frontiers in pharmacology, 2022 - frontiersin.org
Functional gastrointestinal disorders (FGIDs) have been re-named as disorders of gut-brain
interactions. These conditions are not only common in clinical practice, but also in the …

[HTML][HTML] Irritable bowel syndrome: a clinical review

RLS Soares - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) remains a clinical challenge in the 21 st century. It's the most
commonly diagnosed gastrointestinal condition and also the most common reason for …

[HTML][HTML] The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments

MH Farzaei, R Bahramsoltani, M Abdollahi… - Journal of …, 2016 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is the most common disorder referred to gastroenterologists
and is characterized by altered bowel habits, abdominal pain, and bloating. Visceral …

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

L Ruepert, AO Quartero, NJ de Wit… - Cochrane database …, 2011 - cochranelibrary.com
Background Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder.
The role of pharmacotherapy for IBS is limited and focused mainly on symptom control …

National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey

R Mojtabai, M Olfson - The Journal of clinical psychiatry, 2013 - psychiatrist.com
Objective: To assess the trend in long-term use of antidepressants by persons aged≥ 18
years, and the correlates of such use, in the United States from 1999 to 2010. Method: We …

Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners

O Grundmann, SL Yoon - Journal of gastroenterology and …, 2010 - Wiley Online Library
Irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, affects from 3–20% of the
US population, depending on sociocultural and comorbid factors. IBS is characterized by a …